top of page

Centurion Therapeutics Partners with Pensar Medical to Expand Access to Innovative Single Use Negative Pressure Wound Therapy Solution

Aug 30

2 min read

2

7

0


Centurion Therapeutics Pensar Medical Partnership Logo

Centurion Therapeutics is proud to announce a strategic partnership with Pensar Medical, a leader in negative pressure wound therapy (NPWT). This collaboration will focus on distributing the Microdoc® sNPWT (single-use negative pressure wound therapy) platform, a cutting-edge solution designed to enhance patient care and provide advanced wound management across a wide range of healthcare settings.


The Microdoc® sNPWT system represents a breakthrough in wound care, offering a cost-effective and efficient method for treating both chronic and acute wounds. By combining Pensar Medical's innovative technology with our extensive distribution network, we aim to promote the widespread adoption of the Microdoc® platform. This partnership allows us to leverage our network of over 500 sales professionals operating in more than 600 sites of care, bringing the benefits of sNPWT to more patients than ever before.


"The addition of the Microdoc® sNPWT system to our product lineup aligns perfectly with our mission to provide comprehensive wound and surgical management solutions nationwide," said Robert Goodwin, President and CEO of Centurion Therapeutics. "We are thrilled to offer this innovative product to our distribution partners and their customers."


The market for single-use negative pressure wound therapy is rapidly expanding, with an estimated annual growth rate of over 20%. Research has demonstrated that sNPWT can significantly reduce surgical site infections, which currently cost the U.S. healthcare system more than $3.3 billion annually. Devices like Microdoc® have been shown to potentially reduce this risk by more than 50%, underscoring the importance of expanding access to such technologies.


"We are excited to partner with Centurion Therapeutics," said Jason Bandy, CEO of Pensar Medical. "Their strong presence in the inpatient market, combined with our NPWT technology, will enable us to reach more patients and improve outcomes."

This collaboration marks an important step forward in our commitment to advancing wound care and improving patient outcomes. We look forward to working closely with Pensar Medical to make a meaningful impact in the field of wound management.



For more details on this partnership, please read the full press release here.

For information about Microdoc® visit our website here.

Aug 30

2 min read

2

7

0

Comments

Share Your ThoughtsBe the first to write a comment.
bottom of page